Anti-KLK13/ KLK-L4/ KLKL4 functional antibody

Anti-KLK13/ KLK-L4/ KLKL4 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to KLK13/KLK13 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1050-Ab-1/ GM-Tg-hg-SE1050-Ab-2Anti-Human KLK13 monoclonal antibodyHuman
GM-Tg-rg-SE1050-Ab-1/ GM-Tg-rg-SE1050-Ab-2Anti-Rat KLK13 monoclonal antibodyRat
GM-Tg-mg-SE1050-Ab-1/ GM-Tg-mg-SE1050-Ab-2Anti-Mouse KLK13 monoclonal antibodyMouse
GM-Tg-cynog-SE1050-Ab-1/ GM-Tg-cynog-SE1050-Ab-2Anti-Cynomolgus/ Rhesus macaque KLK13 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1050-Ab-1/ GM-Tg-felg-SE1050-Ab-2Anti-Feline KLK13 monoclonal antibodyFeline
GM-Tg-cang-SE1050-Ab-1/ GM-Tg-cang-SE1050-Ab-2Anti-Canine KLK13 monoclonal antibodyCanine
GM-Tg-bovg-SE1050-Ab-1/ GM-Tg-bovg-SE1050-Ab-2Anti-Bovine KLK13 monoclonal antibodyBovine
GM-Tg-equg-SE1050-Ab-1/ GM-Tg-equg-SE1050-Ab-2Anti-Equine KLK13 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1050-Ab-1/ GM-Tg-hg-SE1050-Ab-2; GM-Tg-rg-SE1050-Ab-1/ GM-Tg-rg-SE1050-Ab-2;
GM-Tg-mg-SE1050-Ab-1/ GM-Tg-mg-SE1050-Ab-2; GM-Tg-cynog-SE1050-Ab-1/ GM-Tg-cynog-SE1050-Ab-2;
GM-Tg-felg-SE1050-Ab-1/ GM-Tg-felg-SE1050-Ab-2; GM-Tg-cang-SE1050-Ab-1/ GM-Tg-cang-SE1050-Ab-2;
GM-Tg-bovg-SE1050-Ab-1/ GM-Tg-bovg-SE1050-Ab-2; GM-Tg-equg-SE1050-Ab-1/ GM-Tg-equg-SE1050-Ab-2
Products NameAnti-KLK13 monoclonal antibody
Formatmab
Target NameKLK13
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-KLK13 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1050-Ag-1Recombinant multi-species KLK13/ KLK-L4/ KLKL4 protein
    ORF Viral VectorpGMLP002257human KLK13 Lentivirus plasmid
    ORF Viral VectorvGMLP002257human KLK13 Lentivirus particle
    ORF Viral VectorpGMLPm000974mouse Klk13 Lentivirus plasmid
    ORF Viral VectorvGMLPm000974mouse Klk13 Lentivirus particle


    Target information

    Target IDGM-SE1050
    Target NameKLK13
    Gene ID26085,626834,292848,106994830,100856194,102902318,540297,100067063
    Gene Symbol and SynonymsEgfbp-2,KLK-L4,KLK13,KLKL4,Klnl,mGk-13
    Uniprot AccessionQ9UKR3
    Uniprot Entry NameKLK13_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000167759
    Target ClassificationN/A

    The target: KLK13, gene name: KLK13, also named as KLK-L4, KLKL4. Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Expression of this gene is regulated by steroid hormones and may be useful as a marker for breast cancer. [provided by RefSeq, Jan 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.